FI893297A0 - Menetelmä lääkeaineina käyttökelpoisten (atsa)naftaleenisultaamijohdannaisten valmistamiseksi - Google Patents

Menetelmä lääkeaineina käyttökelpoisten (atsa)naftaleenisultaamijohdannaisten valmistamiseksi

Info

Publication number
FI893297A0
FI893297A0 FI893297A FI893297A FI893297A0 FI 893297 A0 FI893297 A0 FI 893297A0 FI 893297 A FI893297 A FI 893297A FI 893297 A FI893297 A FI 893297A FI 893297 A0 FI893297 A0 FI 893297A0
Authority
FI
Finland
Prior art keywords
aza
drug
preparation
derivatives useful
sulphate derivatives
Prior art date
Application number
FI893297A
Other languages
English (en)
Swedish (sv)
Other versions
FI93114C (fi
FI93114B (fi
FI893297A (fi
Inventor
Marie-Therese Comte
Claude Gueremy
Jean-Luc Malleron
Serge Mignani
Jean-Francois Peyronel
Alain Truchon
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8809218A external-priority patent/FR2633928B1/fr
Priority claimed from FR8902167A external-priority patent/FR2643265B1/fr
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of FI893297A0 publication Critical patent/FI893297A0/fi
Publication of FI893297A publication Critical patent/FI893297A/fi
Application granted granted Critical
Publication of FI93114B publication Critical patent/FI93114B/fi
Publication of FI93114C publication Critical patent/FI93114C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
FI893297A 1988-07-07 1989-07-06 Menetelmä lääkeaineina käyttökelpoisten (atsa)naftaleenisultaamijohdannaisten valmistamiseksi FI93114C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8809218A FR2633928B1 (fr) 1988-07-07 1988-07-07 Derives de (aza)naphtalenesultame, leurs procedes de preparation et les medicaments les contenant
FR8809218 1988-07-07
FR8902167A FR2643265B1 (fr) 1989-02-20 1989-02-20 Derives de (aza)naphto(1,8-cd)isothiazole dioxyde-1,1 leurs procedes de preparation et les medicaments les contenant
FR8902167 1989-02-20

Publications (4)

Publication Number Publication Date
FI893297A0 true FI893297A0 (fi) 1989-07-06
FI893297A FI893297A (fi) 1990-01-08
FI93114B FI93114B (fi) 1994-11-15
FI93114C FI93114C (fi) 1995-02-27

Family

ID=26226778

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893297A FI93114C (fi) 1988-07-07 1989-07-06 Menetelmä lääkeaineina käyttökelpoisten (atsa)naftaleenisultaamijohdannaisten valmistamiseksi

Country Status (18)

Country Link
US (2) US5021420A (fi)
EP (1) EP0350403B1 (fi)
JP (1) JP2763791B2 (fi)
KR (1) KR0138908B1 (fi)
AU (1) AU620114B2 (fi)
CA (1) CA1326483C (fi)
DE (1) DE68904364T2 (fi)
DK (1) DK335489A (fi)
ES (1) ES2054057T3 (fi)
FI (1) FI93114C (fi)
GR (1) GR3006775T3 (fi)
HU (1) HU210833B (fi)
IE (1) IE62364B1 (fi)
IL (1) IL90858A (fi)
NO (1) NO179007C (fi)
NZ (1) NZ229856A (fi)
PT (1) PT91098B (fi)
TW (1) TW197440B (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2663635A2 (fr) * 1989-12-26 1991-12-27 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
FR2656306A1 (fr) * 1989-12-26 1991-06-28 Rhone Poulenc Sante Derives heterocycliques, leur preparation et les medicaments les contenant.
EP0429341A3 (en) * 1989-11-20 1991-11-13 Rhone-Poulenc Sante Heterocyclic derivatives, their preparation and pharmaceuticals containing them
FR2662696A2 (fr) * 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2661177A1 (fr) * 1990-04-23 1991-10-25 Rhone Poulenc Sante Derives du naphtosultame antagonistes de la serotonine, leur preparation et les medicaments les contenant.
FR2675801A1 (fr) * 1991-04-24 1992-10-30 Rhone Poulenc Rorer Sa Piperidines, leur preparation et les medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
US5202321A (en) * 1991-06-13 1993-04-13 Merck Frosst Canada, Inc. Thiopyrano[2,3,4-c,d]indoles as inhibitors of leukotriene biosynthesis
FR2687575A1 (fr) * 1992-02-24 1993-08-27 Rhone Poulenc Rorer Sa Application du [[(fluoro-4 phenyl)-4 piperazinyl-1]-3 propyl]-2 2h naphto [1,8-cd] isothiazole dioxyde-1,1 pour obtenir un medicament anorexigene.
US6001827A (en) 1993-12-24 1999-12-14 Suntory Limited Benzothiazine derivative
WO1995018117A1 (fr) * 1993-12-24 1995-07-06 Suntory Limited Derive de benzothiazine
US5874429A (en) * 1993-12-24 1999-02-23 Suntory Limited Benzothiazine derivative
GB9416571D0 (en) * 1994-08-16 1994-10-12 Battelle Memorial Institute Novel alkylamino derivatives as sigma 2 selective ligands
SE9902765D0 (sv) 1999-07-21 1999-07-21 Astra Pharma Prod Novel compounds
US6521630B1 (en) 1999-08-31 2003-02-18 Pfizer Inc. Tetrahydroquinazoline-2,4-diones and therapeutic uses thereof
US6844338B2 (en) 2000-05-18 2005-01-18 Eli Lilly And Company Piperidyindoles as serotonin receptor ligands
GB2362381A (en) * 2000-05-18 2001-11-21 Lilly Co Eli Pharmaceutically active indolyl-piperidines
WO2006090783A1 (ja) 2005-02-25 2006-08-31 Kowa Co., Ltd. ４－フルオロイソキノリン－５－スルホニルハライド又はその塩の製造方法
CA2679263A1 (en) 2007-02-28 2008-09-04 Asahi Kasei Pharma Corporation Sulfonamide compound
US9359367B2 (en) 2012-07-09 2016-06-07 Lupin Limited Tetrahydroquinazolinone derivatives as PARP inhibitors
CN108299411B (zh) * 2017-01-13 2021-02-05 中国人民解放军军事医学科学院毒物药物研究所 4,4-二苯基哌啶类化合物或其可药用盐、药物组合物及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755589A (fr) * 1969-09-03 1971-03-02 Janssen Pharmaceutica Nv Benzimidazoolcarbamaten
DE2139084C3 (de) * 1971-08-04 1979-03-01 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Verfahren zur Herstellung von 4,4-Diphenyl-piperidinen
US4110449A (en) * 1977-05-23 1978-08-29 E. R. Squibb & Sons, Inc. 2-substituted benzisothiazol-3-ones
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
JPS59229556A (ja) * 1983-06-13 1984-12-24 Konishiroku Photo Ind Co Ltd 熱現像カラ−感光要素
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
GB8510840D0 (en) * 1985-04-29 1985-06-05 Allied Corp Electrical connectors

Also Published As

Publication number Publication date
NZ229856A (en) 1990-08-28
DK335489D0 (da) 1989-07-06
NO179007B (no) 1996-04-09
HUT56098A (en) 1991-07-29
US5036075A (en) 1991-07-30
ES2054057T3 (es) 1994-08-01
IE62364B1 (en) 1995-01-25
PT91098A (pt) 1990-02-08
AU3790689A (en) 1990-01-11
DK335489A (da) 1990-01-08
NO892808L (no) 1990-01-08
KR900001707A (ko) 1990-02-27
NO892808D0 (no) 1989-07-06
FI93114C (fi) 1995-02-27
US5021420A (en) 1991-06-04
TW197440B (fi) 1993-01-01
HU210833B (en) 1995-08-28
EP0350403A1 (fr) 1990-01-10
GR3006775T3 (fi) 1993-06-30
EP0350403B1 (fr) 1993-01-13
PT91098B (pt) 1994-12-30
AU620114B2 (en) 1992-02-13
JP2763791B2 (ja) 1998-06-11
CA1326483C (fr) 1994-01-25
NO179007C (no) 1996-07-17
IL90858A (en) 1994-08-26
FI93114B (fi) 1994-11-15
DE68904364D1 (de) 1993-02-25
FI893297A (fi) 1990-01-08
IL90858A0 (en) 1990-02-09
JPH0267274A (ja) 1990-03-07
IE892189L (en) 1990-01-07
KR0138908B1 (ko) 1998-05-15
DE68904364T2 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
FI893297A0 (fi) Menetelmä lääkeaineina käyttökelpoisten (atsa)naftaleenisultaamijohdannaisten valmistamiseksi
FI891021A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 1,2,4-triatsolijohdannaisten valmistamiseksi
FI881978A0 (fi) Menetelmä eperisonia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI98196B (fi) Menetelmä mikroemulsion käsittävän farmaseuttisen formulaation valmistamiseksi
FI871294A0 (fi) Menetelmä lääkeaineina käyttökelpoisten milbemysiinin johdannaisten valmistamiseksi
FI905326A0 (fi) Menetelmä lääkeaineina käyttökelpoisten imidatso/4,5-b/kinolinyylioksialkaanihappoamidien valmistamiseksi
FI871492A (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
FI892640A0 (fi) Menetelmä piperidinoalkanoli-ibuprofeeniyhdistelmää sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI885884A0 (fi) Menetelmä hitaasti vapautuvan farmaseuttisen koostumuksen valmistamiseksi
FI93214B (fi) Menetelmä ja välituote lääkeaineina käyttökelpoisten 0-(3-amino-2-hydroksipropyyli)-hydroksi-imiinihappohalidien valmistamiseksi
FI98046B (fi) Menetelmä syklosporiinia sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI881103A (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
FI890282A (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
FI891538A (fi) Menetelmä farmaseuttisesti käyttökelpoisten fenolisubstituoitujen gem-difosfonaattijohdannaisten valmistamiseksi
FI103050B1 (fi) Menetelmä N,O-sulfatoituja heparosaaneja sisältävän koostumuksen valmistamiseksi
PT86986A (pt) Substituted 9-amino-tetrahydroacridines and related compounds a process for their preparation and their use as medicaments
FI861987A0 (fi) Piperidylideeni dihydrodibentso/a,d/syklohepteenien ja niiden atsajohdosten valmistusmenetelmä
FI890283A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 25-hydroksi-vitamiinin D-johdannaisten valmistamiseksi
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
FI93107B (fi) Menetelmä lääkeaineina käyttökelpoisten 2-imino-6-polyfluorialkoksibentsotiatsolijohdannaisten valmistamiseksi
NO177485C (no) Fremgangsmåte for fremstilling av et farmasöytisk inhalasjonspreparat
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
PT88681A (pt) A process for the preparation of pharmaceutical compositions containing piperidinoalkanol derivatives
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
FI901606A0 (fi) Tieno-triatsolo-diatsepiinien sulfonyylijohdosten valmistusmenetelmä

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: RHONE-POULENC SANTE